QOP
ROIV icon

Quinn Opportunity Partners’s Roivant Sciences ROIV Stock Holding History

Quinn Opportunity Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$761K Sell
21,500
-8,500
-28% -$251K 0.04% 240
2026
Q1 		$831K Sell
30,000
-10,000
-25% -$257K 0.04% 224
2025
Q4 		$868K Hold
40,000
– – 0.04% 236
2025
Q3 		$605K Hold
40,000
– – 0.04% 222
2025
Q2 		$451K Buy
+40,000
New +$434K 0.04% 251

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Quinn Opportunity Partners's ROIV Position: Q2 2026 in Review

Quinn Opportunity Partners reduced its Roivant Sciences (ROIV) stake by 28% in Q2 2026, selling an estimated $251K and leaving 21,500 shares worth $761K. The position accounts for 0.04% of the portfolio, ranked #240.

Quinn Opportunity Partners first reported a position in ROIV in Q2 2025 and has held it in 5 quarters since. The position peaked at $868K in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Quinn Opportunity Partners held 21,500 shares of Roivant Sciences worth $761K as of Q2 2026.
  • Quinn Opportunity Partners sold 8,500 Roivant Sciences shares in Q2 2026, an estimated $251K.
  • Roivant Sciences made up 0.04% of Quinn Opportunity Partners's portfolio in Q2 2026, its #240 holding.
  • Quinn Opportunity Partners first reported a position in Roivant Sciences in Q2 2025 and has held it in 5 quarters since.
  • Quinn Opportunity Partners's Roivant Sciences position peaked at $868K in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.